{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:02:13Z","timestamp":1780718533376,"version":"3.54.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7239-26","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:09:25Z","timestamp":1780524565000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypertrophic Cardiomyopathy and Sudden Cardiac Arrest Associated with a <i>PSEN1<\/i> Variant: A Case Report"],"prefix":"10.2169","author":[{"given":"Natsuko","family":"Inagaki","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"},{"name":"Department of Clinical Genetics Center, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kamoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kosuge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muryo","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Kiribayashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics Center, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Yazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Tokai University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995.","DOI":"10.1038\/375754a0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. DeStrooper B, Iwatsubo T, Wolfe MS. Presenilins and \u03b3-secretase: structure, function, and role in Alzheimer disease. Cold Spring Harb Perspect Med 2: a006304, 2012.","DOI":"10.1101\/cshperspect.a006304"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870, 1996.","DOI":"10.1038\/nm0896-864"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Li D, Parks SB, Kushner JD, et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 79: 1030-1039, 2006.","DOI":"10.1086\/509900"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gianni D, Li A, Tesco G, et al. Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 121: 1216-1226, 2010.","DOI":"10.1161\/CIRCULATIONAHA.109.879510"},{"key":"6","unstructured":"6. Saito S, Ohno Y, Suzuki T, et al. Presenilin-1 induces cardiomyocyte apoptosis in vivo through alternative splicing and protein degradation. Lab Investig 91: 1645-1656, 2011."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Repetto E, Yoon IS, Zheng H, et al. Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. J Biol Chem 282: 31504-31516, 2007.","DOI":"10.1074\/jbc.M704273200"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 381: 242-255, 2013.","DOI":"10.1016\/S0140-6736(12)60397-3"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102: 858-864, 2000.","DOI":"10.1161\/01.CIR.102.8.858"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Inagaki N, Hayashi T, Takei Y, et al. Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy. Hum Genome Var 9: 6, 2022.","DOI":"10.1038\/s41439-022-00183-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Inagaki N, Okano T, Kobayashi M, et al. Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant. Hum Genome Var 11: 14, 2024.","DOI":"10.1038\/s41439-024-00272-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat 33: 1340-1344, 2012.","DOI":"10.1002\/humu.22117"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yasuda M, Maeda K, Hashimoto M, et al.  A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2. Arch Neurol 56: 65-69, 1999.","DOI":"10.1001\/archneur.56.1.65"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. O'Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J 35: 2010-2020, 2014.","DOI":"10.1093\/eurheartj\/eht439"},{"key":"15","unstructured":"15. Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 44: 3503-3626, 2023."},{"key":"16","unstructured":"16. Ommen SR, Ho CY, et al.; Writing Committee Members. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: A report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. J Am Coll Cardiol 83: 2324-2405, 2024."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Raux G, Guyant-Mar\u00e9chal L, Martin C, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet 42: 793-795, 2005.","DOI":"10.1136\/jmg.2005.033456"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kang DE, Soriano S, Xia X, et al. Presenilin couples the paired phosphorylation of \u03b2-catenin independent of axin: implications for \u03b2-catenin activation in tumorigenesis. Cell 110: 751-762, 2002.","DOI":"10.1016\/S0092-8674(02)00970-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shen J, Kelleher RJ 3rd. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A. 104: 403-409, 2007.","DOI":"10.1073\/pnas.0608332104"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Herreman A, Hartmann D, Annaert W, et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A. 96: 11872-11877, 1999.","DOI":"10.1073\/pnas.96.21.11872"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Etcheberrigaray R, Tan M, Dewachter I, et al. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc Natl Acad Sci U S A. 101: 11141-11146, 2004.","DOI":"10.1073\/pnas.0403921101"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Green KN, Demuro A, Akbari Y, et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid \u03b2 production. J Cell Biol 181: 1107-1116, 2008.","DOI":"10.1083\/jcb.200706171"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kasri NN, Kocks SL, Verbert L, et al. Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 40: 41-51, 2006.","DOI":"10.1016\/j.ceca.2006.03.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol 258 (6 Pt 2): H1796-H1805, 1990.","DOI":"10.1152\/ajpheart.1990.258.6.H1796"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Laudon H, Hansson EM, Mel\u00e9n K, et al. A nine-transmembrane domain topology for presenilin 1. J Biol Chem 280: 35352-35360, 2005.","DOI":"10.1074\/jbc.M507217200"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130: 484-495, 2014.","DOI":"10.1161\/CIRCULATIONAHA.113.007094"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7239-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:32:47Z","timestamp":1780716767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7239-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7239-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7239-26"}}